There's a striking similarity with the SHMP chart in the
There's a striking similarity with the SHMP chart in the following way >
>
> Both AXXA and SHMP blasted out of Bottom Bases in NOV 2018.
>
> SHMP quickly reached a Major Top of about .05 and then had
steep pullback to .01 then steadily moved back to .02+ By Early JAN 2019.
>
> AXXA took a little longer reaching a Major Top of about .035 in JAN 2019
then a steep pullback into March 2019 of about .0085 then has been
steadily moving back up to .017 to now MAY 2019.
>
> The point of this comparison shows IMO AXXA chart is right where SHMP
chart was in early JAN 2019 before it went on its incredible run of
.03 to .50+ in 3 to 4 weeks !!!
>
> While I don't think that exact scenario is ahead for AXXA
because the AXXA chart has taken more time to develop than the
SHMP chart did from NOV 2018 > I do think AXXA longs should be
considering a plausible scenario over the next 8 to 12 weeks where
AXXA could reach its APRIL 2018 Highs in the .15 to .30 range.
>
> This upcoming week will be a critical test to show if the above
scenario is going to play out. What we need to see is STRONGER VOLUME
than last week and a close by FRIDAY MAY 24 above .02+ closing near the top of the
weeks trading range. The coming FINS release and a PR or two about recent
new acquisition developments should provide the CATALYSTS
for a GREEN week ahead.
>
> Good Lock to everyone exciting days ahead.
> Full Disclosure I'm currently long 2M shrs AXXA.
Exxe Group Inc. (AXXA) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Transitioning Power in the CPA World Let's cut to the chase—when a seasoned CPA like Joseph Rabinowitz picks up the phone to secure a succession partner, it's a big deal. Enter ZBS Group LLP, steered by Michael Zaidman, which isn't a stranger to these waters, undertaking their fourth CPA practice acquisition through Rabinowitz's corner of the accounting universe....
Continue Reading
Grit Meets Growth at Latham & Watkins There's grit, then there's growth, and Latham & Watkins seems hell-bent on showcasing both. Promoting 70 associates to the rank of counsel is no small feat, folks. This ain't your run-of-the-mill law firm shuffle; it's a calculated expansion with teeth. Effective January 1, 2027, these promotions will rope in legal heavyweights from...
Continue Reading
Generational Shifts and Ideological Alignments Among Congressional Aides There's no denying it, things are heating up on Capitol Hill—not in chambers, but in the offices. A fresh Capitol Pulse survey is shoving this under the spotlight, dissecting how congressional staffers’ political ideologies stack up against their bosses'. Conducted by CNCT and dissected by...
Continue Reading
Setting the Stage at SEMA 2026 In the chaotic whirl of the 2026 SEMA Show, Massimo Group didn't just roll out new wheels—they took a leap into the big leagues. Amidst the bustling Vegas crowd, Massimo unveiled their latest babies: the Warrior 1500XD and the Sentinel 1500 HVAC Crew. These ain't just any UTVs; they're packing some serious muscle with a 1,499cc engine,...
Continue Reading
WuXi Strikes Gold with ESG Distinction Take a look under the hood, and you’ll find that WuXi Biologics (2269.HK) isn’t just playing the long game—they’re redefining it. They’ve clinched not one, but two prestigious honors from the Hong Kong ESG Reporting Awards (HERA). And with sustainability in the hot seat worldwide, these wins are no small potatoes. They...
Continue Reading
Mac Cummings: A Maverick at Terakeet's Helm So, here’s the deal—we’ve got Mac Cummings, a guy who's shaking up the marketing world just when we thought we had it all figured out. When you get a nod from ADWEEK's Innovator 50, it isn't because you played it safe. It's because you believed in disrupting the status quo. Cummings has taken Terakeet from a humble start...
Continue Reading
Samsung Biologics Achieves a Low-Risk Triumph You gotta hand it to Samsung Biologics for hitting a 'Negligible Risk' rating. Their latest score? A cool 9.0. That’s like walking into the pharmaceuticals room and getting a standing ovation. It's no small feat—climbing up from a 'Low Risk' rating to the top tier in Morningstar Sustainalytics' playbook. For us spectating...
Continue Reading
A Grand Gathering of Robotics Minds Walking into KINTEX, Seoul's suburban behemoth of an exhibition center, you'll find a buzz that rivals the excitement of a stock floor on earnings day. It's ROBOTWORLD 2026, a stage set for tech titans and ambitious startups alike, all throwing in their chips on AI and robotics. From November 4th to 7th, 402 companies hailing from 17...
Continue Reading
Zuellig Pharma's Strategic Leap in Hangzhou You know, in the ever-evolving world of biotech and pharmaceuticals, setting up shop in the right locale can mean the difference between breakthroughs and breakdowns. So Zuellig Pharma—a major player, but not exactly a household ticker—made a smart move acquiring a clinical facility in Hangzhou. This is no minor shuffle;...
Continue Reading
A New Chapter for a Seasoned Leader When a high flyer like Stephanie Knepp steps into a new arena, you know folks are going to sit up and pay attention. This time, she's making waves by joining the Exceptional Women Alliance (EWA), a heavy-hitting community of women leaders. With her extensive background in scaling businesses and empowering leaders, she's bound to bring...
Continue Reading
Top 5 Most Recently Viewed Articles
Encore Wound Care Recognized Among America's Fastest-Growing Companies Encore Achieves New Heights with Impressive Revenue Growth Encore Wound Care has made a remarkable entrance onto the Inc. 5000 list, showcasing its impressive three-year revenue growth of 6,745%. This accolade places Encore at No. 32 overall, while also ranking it No. 2 within its home state and No. 9...
Continue Reading
Magyar Bancorp's Prestigious Recognition in Banking In a noteworthy achievement, Magyar Bancorp, Inc. (NASDAQ: MGYR), the parent company of Magyar Bank, has secured a position on the prestigious KBW Bank Honor Roll for 2025. This accolade highlights the remarkable performance of this institution within a select group of 16 elite banks, showcasing those that exhibit the...
Continue Reading
Class Action Lawsuit Against Open Lending Corporation Open Lending Corporation is currently facing serious allegations that have sparked interest among investors. Robbins LLP has come forward to inform all stockholders that a class action lawsuit has been initiated on behalf of those who purchased or acquired stocks during a specific period. This lawsuit has drawn...
Continue Reading
Breaking New Ground in Global Education Who would've thought that two schools outside the U.S. would be the first to snag the Cognia American School Certification? Yep, John F. Kennedy, The American School of Querétaro in Mexico, and Union School in Haiti have paved the way. This certification ain't just a sticker; it's about meeting a laundry list of rigorous...
Continue Reading
AstraZeneca Class Action Lawsuit: What Investors Need to Know Recent developments at AstraZeneca PLC (NASDAQ: AZN) show a significant opportunity for investors who purchased the pharmaceutical company's securities within a specific time frame. The Rosen Law Firm has initiated a class action lawsuit aimed at addressing securities fraud claims that impact numerous...
Continue Reading